| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701683 | Journal of Thoracic Oncology | 2017 | 29 Pages |
Abstract
Our findings support the clinical validity of quantitative analysis of cfDNA for the prediction of lung cancer survival. Nevertheless, the establishment of a robust standardized method for determination of optimal cutoff thresholds is required to define the clinical relevance of cfDNA quantification for lung cancer management.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Sarah PhD, Pier Luigi MD, Armando A. MD, PhD, Salvatore PhD,